Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06778278 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Transition Health and Resilience Through Valued Experiences (THRiVE) Pilot for Newly Separated Veterans

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 10 wordsv7
  2. Re-verified, no change to tracked fieldsv6
  3. Start date changed from estimate of Jul 31, 2025 to Jul 30, 2025v5
  4. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v4
  5. Re-verified, no change to tracked fieldsv3
  6. Start date: May 31, 2025 to Jul 31, 2025v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of this study is to develop and pilot a program designed to improve mental health outcomes and reduce suicide risk during the transition from military to civilian life. It is hypothesized that the Transition Health and Resilience through Valued Experiences (THRiVE) program, to be developed as part of this study, will meet participant recruitment, retention, and satisfaction benchmarks (primary outcomes) and show positive preliminary effects on mental health symptoms, risk factors for suicidal ideation, and psychosocial functioning outcomes (secondary outcomes). The specific aims of this study are to: 1. Develop a small-group, peer-led, cross-cutting prevention program for newly separated veterans (NSVs) called THRiVE and 2. Evaluate the feasibility, acceptability, and preliminary effects of the THRiVE program on mental health symptoms, risk factors for suicidal ideation, and psychosocial functioning outcomes. Up to 40 NSVs participating in this Stage 1 pilot study will complete validated self-report measures at baseline, immediately after completing the THRiVE program (post-THRiVE), and 3 months after completing the THRiVE program (follow-up). The duration of a participant's time in the study is anticipated to be 5 months.
Trial Details
NCT Number NCT06778278
Lead Sponsor RTI International
Collaborators: U.S. Army Medical Research Acquisition Activity
Conditions
(from sponsor)		 Military Transition, Community Reintegration, Mental Health, Suicidal Ideation, Alcohol Misuse
Related terms Psychological Well-Being, Suicidal Ideation
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov